Annual CFO
-$40.89 M
-$5.93 M-16.96%
31 December 2023
Summary:
Hepion Pharmaceuticals annual cash flow from operations is currently -$40.89 million, with the most recent change of -$5.93 million (-16.96%) on 31 December 2023. During the last 3 years, it has fallen by -$24.72 million (-152.94%). HEPA annual CFO is now -2899.70% below its all-time high of -$1.36 million, reached on 30 June 2014.HEPA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.52 M
+$8.41 M+76.96%
30 September 2024
Summary:
Hepion Pharmaceuticals quarterly cash flow from operations is currently -$2.52 million, with the most recent change of +$8.41 million (+76.96%) on 30 September 2024. Over the past year, it has increased by +$8.72 million (+77.59%). HEPA quarterly CFO is now -2174.53% below its all-time high of -$110.70 thousand, reached on 30 September 2013.HEPA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$26.07 M
+$8.72 M+25.06%
30 September 2024
Summary:
Hepion Pharmaceuticals TTM cash flow from operations is currently -$26.07 million, with the most recent change of +$8.72 million (+25.06%) on 30 September 2024. Over the past year, it has increased by +$10.62 million (+28.95%). HEPA TTM CFO is now -23445.80% below its all-time high of -$110.70 thousand, reached on 30 September 2013.HEPA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HEPA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.0% | +77.6% | +28.9% |
| 3 y3 years | -152.9% | +77.8% | +8.1% |
| 5 y5 years | -161.3% | -39.7% | -155.1% |
HEPA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -152.9% | at low | at high | +79.9% | at high | +36.3% |
| 5 y | 5 years | -440.5% | at low | -39.7% | +79.9% | -244.6% | +36.3% |
| alltime | all time | -2899.7% | at low | -2174.5% | +79.9% | <-9999.0% | +36.3% |
Hepion Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.52 M(-77.0%) | -$26.07 M(-25.1%) |
| June 2024 | - | -$10.93 M(+202.2%) | -$34.78 M(-4.2%) |
| Mar 2024 | - | -$3.62 M(-59.8%) | -$36.29 M(-11.2%) |
| Dec 2023 | -$40.89 M(+17.0%) | -$9.00 M(-19.9%) | -$40.89 M(+11.5%) |
| Sept 2023 | - | -$11.24 M(-9.6%) | -$36.68 M(-3.4%) |
| June 2023 | - | -$12.44 M(+51.4%) | -$37.98 M(+14.9%) |
| Mar 2023 | - | -$8.21 M(+71.2%) | -$33.05 M(-5.5%) |
| Dec 2022 | -$34.96 M(+12.0%) | -$4.80 M(-61.7%) | -$34.96 M(-6.9%) |
| Sept 2022 | - | -$12.53 M(+67.1%) | -$37.55 M(+3.3%) |
| June 2022 | - | -$7.50 M(-26.0%) | -$36.33 M(+6.9%) |
| Mar 2022 | - | -$10.13 M(+37.2%) | -$34.00 M(+8.9%) |
| Dec 2021 | -$31.22 M(+93.2%) | -$7.38 M(-34.8%) | -$31.22 M(+10.1%) |
| Sept 2021 | - | -$11.32 M(+119.0%) | -$28.37 M(+35.8%) |
| June 2021 | - | -$5.17 M(-29.7%) | -$20.89 M(+10.9%) |
| Mar 2021 | - | -$7.35 M(+62.4%) | -$18.84 M(+16.5%) |
| Dec 2020 | -$16.17 M(+113.7%) | -$4.53 M(+17.5%) | -$16.17 M(+14.8%) |
| Sept 2020 | - | -$3.85 M(+23.8%) | -$14.08 M(+17.0%) |
| June 2020 | - | -$3.11 M(-33.5%) | -$12.03 M(+18.1%) |
| Mar 2020 | - | -$4.68 M(+91.7%) | -$10.18 M(+34.6%) |
| Dec 2019 | -$7.57 M | -$2.44 M(+35.3%) | -$7.57 M(-26.0%) |
| Sept 2019 | - | -$1.80 M(+42.7%) | -$10.22 M(-14.6%) |
| June 2019 | - | -$1.26 M(-38.6%) | -$11.96 M(-15.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$2.06 M(-59.6%) | -$14.11 M(-9.8%) |
| Dec 2018 | -$15.65 M(+90.6%) | -$5.09 M(+43.7%) | -$15.65 M(+48.3%) |
| Sept 2018 | - | -$3.54 M(+3.7%) | -$10.55 M(-14.8%) |
| June 2018 | - | -$3.42 M(-4.9%) | -$12.38 M(-6.3%) |
| Mar 2018 | - | -$3.59 M(-33.1%) | -$13.21 M(-34.5%) |
| Dec 2017 | -$8.21 M(-57.2%) | - | - |
| Sept 2017 | - | -$5.37 M(+26.5%) | -$20.17 M(+5.2%) |
| June 2017 | -$19.17 M(+15.8%) | -$4.25 M(-18.4%) | -$19.17 M(-0.8%) |
| Mar 2017 | - | -$5.20 M(-2.5%) | -$19.32 M(+7.4%) |
| Dec 2016 | - | -$5.34 M(+22.0%) | -$17.99 M(-0.8%) |
| Sept 2016 | - | -$4.38 M(-0.4%) | -$18.13 M(+9.5%) |
| June 2016 | -$16.56 M(+71.2%) | -$4.40 M(+13.4%) | -$16.56 M(+0.3%) |
| Mar 2016 | - | -$3.88 M(-29.3%) | -$16.50 M(+6.6%) |
| Dec 2015 | - | -$5.48 M(+96.0%) | -$15.48 M(+35.4%) |
| Sept 2015 | - | -$2.80 M(-35.5%) | -$11.43 M(+18.2%) |
| June 2015 | -$9.67 M(+609.6%) | -$4.34 M(+51.7%) | -$9.67 M(+60.5%) |
| Mar 2015 | - | -$2.86 M(+99.6%) | -$6.03 M(+72.1%) |
| Dec 2014 | - | -$1.43 M(+38.0%) | -$3.50 M(+52.9%) |
| Sept 2014 | - | -$1.04 M(+50.0%) | -$2.29 M(+68.1%) |
| June 2014 | -$1.36 M | -$692.40 K(+105.3%) | -$1.36 M(+103.3%) |
| Mar 2014 | - | -$337.20 K(+51.4%) | -$670.60 K(+101.1%) |
| Dec 2013 | - | -$222.70 K(+101.2%) | -$333.40 K(+201.2%) |
| Sept 2013 | - | -$110.70 K | -$110.70 K |
FAQ
- What is Hepion Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual CFO year-on-year change?
- What is Hepion Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly CFO year-on-year change?
- What is Hepion Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals TTM CFO year-on-year change?
What is Hepion Pharmaceuticals annual cash flow from operations?
The current annual CFO of HEPA is -$40.89 M
What is the all time high annual CFO for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual cash flow from operations is -$1.36 M
What is Hepion Pharmaceuticals annual CFO year-on-year change?
Over the past year, HEPA annual cash flow from operations has changed by -$5.93 M (-16.96%)
What is Hepion Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of HEPA is -$2.52 M
What is the all time high quarterly CFO for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly cash flow from operations is -$110.70 K
What is Hepion Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, HEPA quarterly cash flow from operations has changed by +$8.72 M (+77.59%)
What is Hepion Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of HEPA is -$26.07 M
What is the all time high TTM CFO for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high TTM cash flow from operations is -$110.70 K
What is Hepion Pharmaceuticals TTM CFO year-on-year change?
Over the past year, HEPA TTM cash flow from operations has changed by +$10.62 M (+28.95%)